CCNYL7

Across TCGA pan-cancer cohorts, CCNYL7 RNA is linked to patient survival in 18 of 34 cancer types, making it the most broadly survival-associated CCNYL7 data layer.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where higher CCNYL7 RNA is associated with better disease-free survival. In most high-consensus cancer types, elevated CCNYL7 expression acts as an unfavorable survival marker, although some lineages such as HNSC and READ show a favorable association.

HNSC, READ, and COAD are the cancer types where CCNYL7 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
HNSC	DFS	Quartile	II,III,IV	0.398	0.288	.007	49	view →
READ	OS	Median	III,IV	0.911	0.398	.001	39	view →
COAD	DFS	Quartile	IV	0.208	0.572	<.001	34	view →
UVM	DFS	Median	III,IV	0.325	0.720	.001	29	view →
ACC	DFS	Quartile	III,IV	0.543	0.085	.006	23	view →
THYM	OS	Tertile	All	0.875	1.000	.018	17	view →
LIHC	OS	Quartile	II,III,IV	0.802	0.335	.007	16	view →
KIRP	OS	Quartile	All	0.581	0.855	.001	16	view →
SKCM	DFS	Median	II,III,IV	0.785	0.620	.009	15	view →
MESO	OS	Median	III,IV	0.719	0.355	.015	12	view →
LUAD	DFS	Tertile	IV	0.333	0.788	.045	12	view →
GBM	DFS	Quartile	All	0.369	0.225	.010	6	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 18 lineages.

CCNYL7–HNSC (DFS)

Open the HNSC breakdown →